XML 47 R25.htm IDEA: XBRL DOCUMENT

Selected Quarterly Financial Data

12 Months Ended

Dec. 31, 2020

17. Selected Quarterly Financial Data (unaudited) –

The following table contains selected quarterly financial information from 2020 and 2019. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair statement of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.


	Three months ended
	March 31, 2020		June 30, 2020		September 30, 2020		December 31, 2020
		(in thousands, except per share data)
Total collaboration and other research and development revenues	$	5,723	$	10,749	$	62,841	$	11,419
Total operating expenses		52,339		42,088		53,852		77,293
Total other income (expense), net		8,892		7,767		(1,170)		3,375
Net (loss) income	$	(37,724)	$	(23,572)	$	7,819	$	(62,499)
Net (loss) income applicable to common stockholders	$	(37,724)	$	(23,572)	$	7,819	$	(62,499)
Net (loss) income per share attributable to common shareholders:
Basic	$	(0.69)	$	(0.43)	$	0.13	$	(1.00)
Diluted	$	(0.69)	$	(0.43)	$	0.12	$	(1.00)

	Three months ended
	March 31, 2019		June 30, 2019		September 30, 2019		December 31, 2019
		(in thousands, except per share data)
Total collaboration and other research and development revenues	$	2,069	$	2,330	$	3,848	$	12,284
Total operating expenses		33,331		37,979		38,436		51,707
Total other income (expense), net		2,013		1,863		1,647		1,653
Net loss	$	(29,249)	$	(33,786)	$	(32,941)	$	(37,770)
Net loss applicable to common stockholders	$	(29,249)	$	(33,786)	$	(32,941)	$	(37,770)
Net loss per share applicable to common stockholders — basic and diluted	$	(0.60)	$	(0.69)	$	(0.66)	$	(0.74)